Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 2020

View Archived Issues

Pigs with NLRP3 gain-of-function mutation mimic the pathogenesis of human CAPS

Transgenic mice allow study of erythroferrone overexpression

IMV provides update on the development of DPX-COVID-19

CART-Ddbcma leads to rapid and durable responses in relapsed/refractory multiple myeloma

KIAA1429 as potential prognostic biomarker in DLBCL

Janssen describes new PD-L1 antagonists

Istituto Europeo di Oncologia and IFOM patent NEDD-4 inhibitors

Boehringer Ingelheim identifies NMDA NR2B receptor negative allosteric modulators

China Pharmaceutical University, SIMM disclose E-FABP/A-FABP inhibitors

CYAD-211 demonstrates antitumor efficacy in xenograft models of multiple myeloma

New acetyl-CoA carboxylase inhibitors discovered at Almirall

Lynparza approved in Japan for ovarian, prostate and pancreatic cancer

Novavax initiates phase III trial of NVX-CoV2373 COVID-19 vaccine candidate in U.S. and Mexico

Arcturus cleared to begin phase II study of COVID-19 vaccine candidate ARCT-021

New CTP synthase 1 inhibitors described by Step Pharma

Universitaet Regensburg, Universitaet zu Koeln present CD25-specific CAR

Redwood reports further phase II data analysis on RP-101 for dry eye

Celltrion seeks conditional marketing authorization in Korea for CT-P59

Novel mouse model carries mouse homologue of X-linked neutropenia WASp mutation I290T

Lysogene reports biomarker data from AAVance trial of LYS-SAF-302 for MPS IIIA

Condensates open new vistas in cell biology, therapeutics